Abstract
The presend study is a retrospective case–control study included 218 infants with gestation age less than 32 weeks hospitalised in the neonatal ICU during 1999–2002. Frequency of the candidemia was 5%. Mortality in newborns with candidemia was 91%. Statistical analysis demonstrated the following significant risk factors for candidemia, including gestation age <29 weeks, birth weight <1000 gram, use of carbapenems (p<0,05). Apgar <5, duration of the parenteral nutrition, duration of the intubation, use of steroids, theophylline, diuretics, aminoglycosides, cephalosporins, penicillins, fluoroquinolones, metronidazole, gastrointestinal tract colonization, were not independent risk factors.
-
1.
Самсыгина Г.А. Кандидоз новорожденных и детей раннего возраста. Пособие для врачей. М.: Изд-во Минздрава РФ; 1996. – 76 с.
-
2.
Kaufman D. Fungal infection in the very low birthweight infant. Curr Opin Infect Dis 2004; 17:253-9.
-
3.
Романюк Ф.П., Шабалов Н.П. Неонатальный канди- доз. Педиатрия 1995; (3). 77-81.
-
4.
Stoll B.J., Gordon T., Korones S.B. Late-onset sepsis in very low birht weight neonates: a report from the National Institute of Child Health and Human Development neonatal research network. J Pediatr 1996; 129:63-71.
-
5.
Saiman L., Ludington E., Pfaller M., et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000; 19:319-24.
-
6.
Roilides E., Farmaki E., Evdoridou J., et al. Neonatal can- didiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Europ J Clin Microbial Infect Dis 2004; 23:745-50.
-
7.
Leibovitz E. Neonatal candidosis: clinical picture, man- agement controversies and consensus, and new therapeu- tic options. J Antimicrob Chemother 2002; 49:69-73.
-
8.
McGuire W., Clerihew L., Austin N. Prophylactic intra- venous antifungal agents to prevent mortality and mor- bidity in very low birth weight infants (Cochrane Review). The Cochrane Library, Issue 1 2003. Oxford: Update Software.
-
9.
McQuay H.J., Moore R.A. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126:712-20.
-
10.
Ascioglu S., Rex J.H., Pauw B., et al. Defining oppor- tunistic invasive fungal infections in immunocompro- mised patients with cancer and hematopoietic stem cell transplant: an Internation consensus. Clin Infect Dis 2002; 34:7-14.
-
11.
Гублер Е.В. Вычислительные методы анализа и рас- познавания патологических процессов. Л.: Медицина; 1979. – 296 с.
-
12.
Benjamin D.K., Poole C., Steinbach W.J., Rowen J.L., Walsh T.J. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003; 112:634-40.
-
13.
Chapman R.L., Faix R.G. Persistently positive cultures and outcome in invasive neonatal candidiasis. Ped Infect Dis J 2000; 19:822-7.
-
14.
Kicklighter S.D., Springer S.C., Cox T., Hulsey T.C., Turner R.B. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107:293-8.